Survival and cellular immune functions in septic mice treated with growth hormone (GH) and insulin-like growth factor-I (IGF-I)

Growth Hormone and IGF Research

Volumn 18, Issue 3, 2008, Pages 245-252

  Schmitz, Daniel ^a   Kobbe, Phillip ^b   Lendemanns, Sven ^a   Wilsenack, Klaus ^a   Exton, Michael ^a   Schedlowski, Manfred ^a   Oberbeck, Reiner ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Growth hormone; IGF; Immune function; Mouse; Sepsis

Indexed keywords

CYTOKINE; GLUCOSE; HUMAN GROWTH HORMONE; INTERLEUKIN 2; INTERLEUKIN 6; LIPOCORTIN 5; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; BODY TEMPERATURE; BODY WEIGHT; CELL FUNCTION; CELL PROLIFERATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID INTAKE; FLUORESCENCE ACTIVATED CELL SORTING; FOOD INTAKE; GLUCOSE BLOOD LEVEL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SPLEEN CELL; SURVIVAL RATE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; GROWTH HORMONE; IMMUNITY, CELLULAR; LEUKOCYTE COUNT; MALE; MICE; RANDOM ALLOCATION; SEPSIS; SOMATOMEDINS; SPLEEN; SURVIVAL ANALYSIS;

EID: 41649085155     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.10.002     Document Type: Article

References (48)

1. Demling R. Growth hormone therapy in critically ill patients. New Engl. J. Med. 341 (1999) 837
2. Knox J., Demling R., Wilmore D., Sarraf P., and Santos A. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J. Trauma 39 (1995) 526-530
3. Herndon D.N., Barrow R.E., Kunkel K.R., Broemling L., and Rutan R.L. Effect of recombinant human growth hormone on donor site healing in severely burned children. Ann. Surg. 212 (1990) 424-429
4. Chang D.W., DeSanti L., and Demling R. Antianabolic and anabolic strategies in critical illness: a review of current treatment modalities. Shock 10 (1998) 155-160
5. Voerman H.J., Strack van Schindel R.J.M., Groeneveld A.B.J., et al. Effects of recombinant human growth hormone in patients with severs sepsis. Ann. Surg. 216 (1992) 648-655
6. Van den Berghe G. Bad news about growth hormone treatment in the intensive care unit: need for some clarification. Curr. Opin. Anaesth. 14 (2001) 127-129
7. Takala J., Ruokonen E., Webster N.R., et al. Increased mortality associated with growth hormone treatment in critically ill adults. New Engl. J. Med. 341 (1999) 785-793
8. Inoue T., Saito H., Fukushima R., et al. GH and IGF-I enhance host defence in a murine sepsis model. Arch. Surg. 130 (1995) 1115-1122
9. Inoue T., Saito H., Matsuda T., et al. GH and IGF-I augment bactericidal capacity of human polymorphnuclear neutrophils. Shock 10 (1998) 278-284
10. Zarkesh-Esfahani S.H., Kolstad O., Metcalf R.A., Watson P.F., Weetman A.P., and Ross R.J. High-dose growth hormone does not affect proinflammatory cytokine TNF-alpha, IL-6, IFN-gamma) release from activated peripheral blood mononuclear cells after minimal to moderate surgical stress. J. Clin. Endocrinol. Metab. 85 (2000) 3339-3383
11. Takagi K., Suzuki F., Barrow R.E., Wolf S.E., Kobayashi M., and Herndon D.N. Growth hormone improves the resistance of thermally injured mice infected with herpes simplex virus type 1. J. Trauma 44 (1998) 517-522
12. Heemskerk V.H., Daemen M.A.R.C., and Buurman W.A. Insulin-like growth factor I and growth hormone in immunity and inflammation. Cytokine Growth Fact. Rev. 10 (1999) 5-14
13. Kappel M., Hansen M.B., Damant M., Jorgensen J.O.L., Gyhrs A., and Pettersen B.K. Effects of an acute bolus of growth hormone infusion on the human immune system. Horm. Metab. Res. 25 (1993) 579-585
14. Sneppen S.B., Mersebach H., Ullum H., and Feldt-Reasmussen U. Immune function during GH-treatment in GH-deficient adults: an 18-month randomized, placebo-controlled, double blinded trial. Clin. Endocrinol. 57 (2002) 787-792
15. Unneberg K., Balteskard L., Mjaaland M., and Revhaug A. Growth hormone impaired compensation of hemorrhagic shock after trauma and sepsis in swine. J. Trauma 41 (1996) 775-780
16. Schurmann A., Spencer G.S.G., Berry C.J., Decuypere E., and Goddseeris B. Evidence for suppression of immune function by insulin-like growth factor-I in dwarf rats in vivo. Experentia 52 (1996) 55-59
17. Balteskard L., Unneberg K., Halvorsen D., Hansen J.B., and Revhaug A. Effects of IGF-I on neutrophile and monocyte functions in normal and septic states. J. Parent. Enter. Nutr. 22 (1998) 127-135
18. Cameron C.M., and Kostyo J.L. Influence of age on responsiveness to diabetogenic action of growth hormone. Diabetes 36 (1987) 88-92
19. Okamura K., Okuma T., Tabira Y., and Miyauchi Y. Effect of administered human GH on protein metabolism in septic rats. J. Parent. Enter. Nutr. 13 (1989) 450-454
20. Weekers F., Michalaki M., Coopmans W., Veldhius J.D., Darras V.M., and van den Berghe G. Endocrine and metabolic effects of GH compared with GH-RH, TRH, and insulin infusion in a rabbit model of prolonged critical illness. Endocrinol. 145 (2004) 205-213
21. Fukushima R., Saito H., Inoue T., et al. Prophylactic treatment with growth hormone and insulin-like growth factor-I improve systemic bacterial clearance and survival in a murine model of burn-induced gut-derived sepsis. Burns 25 (1999) 425-430
22. Kawata T., Tokimasa C., Fujita T., Kaku M., Shigekawa M., and Tanne K. Effect of insulin-like growth factor I on femoral bone modelling in growing mice. Exp. Anim. 51 (2002) 521-529
23. Lopez-Oliv M.E., Agis Forres A., Unzaga M.T., and Munoz-Martinez E. Feed intake and protein skeletal muscle in growing mice treated with growth hormone: time course effects. J. Physiol. Biochem. 56 (2000) 9-14
24. Baker C.C., Chaudry I.H., Gaines H.O., and Baue A.E. Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 94 (1983) 331-342
25. Exton M.S., Hörsten S.v., Schulte M., et al. Behaviourally conditioned immunosupression using cyclosporine A. J. Neuroimmunol. 88 (1998) 182-191
26. Kelley K.W., Weigent D.A., and Kooijmann R. Protein hormones and immunity. Brain Behav. Immun. 21 (2007) 384-392
27. Clark R. The somatogenic hormones and IGF-I: stimulators of lymphopoesis and immune function. Endocr. Rev. 18 (1997) 157-179
28. Vaan Buul-Offers S.C., and Koojman R. The role of growth hormone and IGFs in the immune system. Cell. Mol. Life Sci. 54 (1998) 1083-1094
29. Murphy W.J., and Longo D.L. Growth hormone as an immunomodulating therapeutic agent. Immunol. Today 21 (2000) 211-213
30. Balteskard L., Unneberg K., Halvorsen D., et al. The influence of GH on tumor necrosis factor and neutrophil leukocyte function in sepsis. Scand. J. Infect. Dis. 29 (1997) 393-399
31. Liu Z., Yu Y., Jiang Y., and Li J. Growth hormone increases circulating neutrophil activation and provokes lung micorvascular injury in septic peritonitis rats. J. Surg. Res. 105 (2002) 195-199
32. Inoue T., Saito H., Tsuno N., et al. Effects of growth hormone and insulin-like growth factor I on opsonin receptor expression on local and systemic phagocytes in a lethal peritonitis model. Crit. Care Med. 26 (1998) 338-343
33. Huang Y., Wang S.R., Yi C., Ying M.Y., Lin Y., and Zhi M.H. Effects of recombinant human growth hormone on rat septic shock with intraabdominal infection by E. coli. World J. Gastroenterol. 8 (2002) 1134-1137
34. Uronen-Hansson H., Allen M.L., Cole T.J., Hoiden-Guthenberg I., Fryklund L., and Klein N. Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood. Growth Horm. IGF Res. 13 (2003) 282-286
35. Matsuda T., Saito H., Inoue T., et al. Growth hormone inhibits apoptosis and up-regulates reactive oxygen intermediates production by human polymorphnuclear neutrophils. J. Parent. Enter. Nutr. 22 (1998) 368-374
36. Oberbeck R., Schmitz D., Wilsenack K., et al. Prolactin reduces survival and immune functions during sepsis in mice. J. Surg. Res. 113 (2003) 248-256
37. Oberbeck R. Therapeutic implications of endocrine-immune interactions in critically ill patients. Curr. Drug Targ. 4 (2004) 129-139
38. Oberbeck R. Catecholamines: physiologic immunomodualtors during health and illness. Curr. Med. Chem. 13 (2006) 1979-1989
39. Wolf S.E., Woodside K.J., Ramirez R.J., Kobayashi M., Suzuki F., and Herndon D.N. Insulin-like growth factor-I/insulin-like growth factor binding protein 3 alters lymphocyte responsiveness following severe burn. J. Surg. Res. 117 (2004) 255-261
40. Mitsunaka H., Dobashi H., Sato M., et al. Growth hormone prevents Fas-induced apoptosis in lymphocytes through modulation of Bcl-2 and caspase 3. Neuroimmunomodulation 9 (2001) 256-262
41. Geffner M. Effects of growth hormone and insulin-like growth factor I on T- and B-lymphocytes and immune function. Acta Paediatr. Suppl. 423 (1997) 76-79
42. Alpdogan O., Muriglan S.J., Kappel B.J., et al. Insulin-like growth factor I enhances lymphoid and myeloid reconstitution after allogenic bone marrow transplantation. Transplantation 75 (2003) 1977
43. Takagi K., Suzuki F., Barrow R.E., Wolf S.E., and Herndon D.N. Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice. Ann. Surg. 228 (1998) 106-111
44. Jeschke M.G., Barow R.E., and Herndon D.N. IGF-I plus IGF-BP3 attenuate the proinflammatory acute phase response in severely burned child. Ann. Surg. 231 (2000) 246-252
45. Kooijman R., and Coppens A. Insulin-like growth factor I stimulates IL-10 production in human T-cells. J. Leukoc. Biol. 76 (2004) 862-867
46. Fernandez M., Medina A., Santos F., Carbajo E., Rodriguez J., and Cobo A. Exacerbated inflammatory response induced by insulin-like growth factor I treatment in rats with ischemic acute renal failure. J. Am. Soc. Nephrol. 12 (2001) 1900-1907
47. Hermansson M., Wickelgreen R.B., and Hammerquivst F. Measurement of human growth hormone receptor messenger ribonucleid acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery. J. Clin. Endocrin. Metab. 82 (1997) 421-428
48. Van den Berghe G. Increased mortality associated with growth hormone treatment in critically ill adults (Correspondence). New Engl. J. Med. 342 (2000) 134-136